Thomas Lam compensation by year
Astrana Health Summary Compensation Table · all 8 fiscal years held| Component | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|
| Salary | $489,550 | $950,000 | $950,000 | $950,000 | $950,000 | $950,000 | $950,000 | $950,000 |
| Bonus | $350,000 | $0 | $100,000 | $100,000 | $0 | $450,000 | $1,000,000 | — |
| Stock awards | $0 | $0 | $1,133,619 | $1,160,003 | $4,661,541 | $0 | $3,253,500 | $1,878,400 |
| Option awards | $0 | $0 | $290,000 | $290,000 | $1,115,766 | $0 | $0 | — |
| Non-equity incentive | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — |
| All other | $6,640 | $14,841 | $15,525 | $15,139 | $129,887 | $87,709 | $14,062 | $14,662 |
| Total | $846,189 | $964,841 | $2,489,144 | $2,515,142 | $6,857,194 | $1,487,709 | $5,217,562 | $2,843,062 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Astrana Health, Inc. DEF 14A filed April 25, 2025, accession 0001104659-25-039438, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Astrana Health, Inc. filed document, accession 0001104659-25-039438. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2025.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 90,000 | $2,837,700 | — |
| RSU | 40,000 | $1,261,200 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Astrana Health, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
6 Form 4 lines since the FY2024 proxy (filed April 25, 2025)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-10-06 | Tax withholding | — | 2,624 | $37.00 | 463,033 |
| 2026-04-06 | Grant or award | — | 41,667 | $0.00 | 465,657 |
| 2026-03-05 | Tax withholding | — | 9,266 | $25.07 | 423,990 |
| 2025-12-08 | Exercise or conversion | — | 29,502 | $17.78 | 459,122 |
| 2025-12-08 | Tax withholding | — | 25,866 | $22.00 | 433,256 |
| 2025-12-08 | Exercise or conversion derivative | — | 29,502 | $0.00 | 0 |
The 6 most recent of 6 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Astrana Health’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Brandon Sim | Executive Chairman | $18,242,585 |
| Dinesh Kumar | Chief Medical Officer | $10,390,830 |
| Chandan Basho | Chief Financial Officer and Chief Operating Officer | $5,460,490 |
| Thomas Lam · this page | Vice Chairman (former Co-Chief Executive Officer) | $2,843,062 |
| Albert Young | SVP of Health Affairs (former Chief Administrative Officer) | $452,281 |
Board service
Astrana Health board · FY2023–FY2025| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | — | — | $0 | $992,530 | $992,530 |
| FY2023 | — | — | — | — | — |
Each year as the company reported it in Astrana Health's director compensation table. Totals are the company's own disclosed totals.
How this board is paid
Company policy: Astrana Health pays directors a $80,000 cash retainer and $170,000 in Restricted Stock. As stated in Astrana Health's FY2025 proxy.
The full Astrana Health compensation record
free company briefThis page is one person within Astrana Health's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Astrana Health proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Astrana Health's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.